Express News | Bristol-Myers Squibb: Opdivo in combination with cisplatin chemotherapy approved for first-line treatment of urothelial carcinoma.
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy Right Now?
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
How Is The Market Feeling About Bristol-Myers Squibb?
Express News | Bristol-Myers Squibb Co : Leerink Partners Raises Target Price to $55 From $53
Bristol-Myers Squibb Company PFD CONV 2 Goes Ex Dividend Tomorrow